Virtu Financial LLC Bridge Bio Pharma, Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$24.02 - $43.89 $145,873 - $266,543	6,073 New	6,073 $245,000
Q1 2022 May 17, 2022	SELL	$7.34 - $17.16 $790,569 - $1.85 Million	-107,707 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$11.38 - $53.41 $1.23 Million - $5.75 Million	107,707 New	107,707 $1.8 Million
Q1 2021 May 19, 2021	SELL	$55.47 - $72.35 $311,852 - $406,751	-5,622 Closed	0 $0
Q4 2020 Feb 24, 2021	SELL	$38.38 - $71.11 $25,561 - $47,359	-666 Reduced 10.59%	5,622 $400,000
Q3 2020 Dec 11, 2020	BUY	$27.2 - $42.19 $171,033 - $265,290	6,288 New	6,288 $236,000
Q2 2020 Aug 07, 2020	SELL	$22.22 - $35.69 $145,696 - $234,019	-6,557 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$17.96 - $46.63 $117,763 - $305,752	6,557 New	6,557 $230,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.